SCHEMBL169092

SCHEMBL169092

CC(O)CCNCc1cccc(OC(F)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 3/20 0.49
PRMT6 Q96LA8 3/20 0.49
USP28 Q96RU2 1/20 0.48
USP25 Q9UHP3 1/20 0.48
CETP P11597 4/20 0.48
GLS O94925 1/20 0.48
CHRM2 P08172 2/20 0.47
CNR1 P21554 2/20 0.47
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47
MAPK14 Q16539 1/20 0.46
VNN1 O95497 1/20 0.45
ROCK2 O75116 1/20 0.44
ROCK1 Q13464 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM5A P29375 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
KDM5B Q9UGL1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20776850 0.82 CARM1 (0.51) CARM1PRMT6USP28USP25CETP
SCHEMBL14966127 0.82 USP28 (0.62) CARM1PRMT6USP28USP25CETP
SCHEMBL1416997 0.82 CETP (0.56) CETPCHRM2CNR1CHRM1CHRM3
SCHEMBL14966126 0.81 CETP (0.52) CARM1PRMT6CETPCHRM2CHRM1
SCHEMBL169091 0.80 CETP (0.49) CARM1PRMT6CETPCHRM2CHRM1
SCHEMBL9902980 0.79 CHRM2 (0.50) CARM1PRMT6USP28USP25CETP
SCHEMBL12963217 0.79 CHRM2 (0.51) CARM1PRMT6USP28USP25CETP
SCHEMBL3285226 0.78 CETP (0.65) CETPMAPK14ROCK2ROCK1
SCHEMBL4598244 0.78 CHRM2 (0.54) CARM1PRMT6USP28USP25CETP
SCHEMBL16268378 0.78 CARM1 (0.48) CARM1PRMT6USP28USP25CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed